Ellen Lubman insider trades
Open-market stock purchases and sales by Ellen Lubman, Chief Business Officer at Werewolf Therapeutics, Inc, from SEC Form 4 filings since Aug 3, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- HOWL Werewolf Therapeutics, Inc: other filings, last Jan 2, 2025